These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 39358807)

  • 1. Deep learning-based analysis of EGFR mutation prevalence in lung adenocarcinoma H&E whole slide images.
    Park JH; Lim JH; Kim S; Kim CH; Choi JS; Lim JH; Kim L; Chang JW; Park D; Lee MW; Kim S; Park IS; Han SH; Shin E; Roh J; Heo J
    J Pathol Clin Res; 2024 Nov; 10(6):e70004. PubMed ID: 39358807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Epidermal Growth Factor Receptor Mutation Subtypes in Non-Small Cell Lung Cancer From Hematoxylin and Eosin-Stained Slides Using Deep Learning.
    Zhang W; Wang W; Xu Y; Wu K; Shi J; Li M; Feng Z; Liu Y; Zheng Y; Wu H
    Lab Invest; 2024 Aug; 104(8):102094. PubMed ID: 38871058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep learning-based six-type classifier for lung cancer and mimics from histopathological whole slide images: a retrospective study.
    Yang H; Chen L; Cheng Z; Yang M; Wang J; Lin C; Wang Y; Huang L; Chen Y; Peng S; Ke Z; Li W
    BMC Med; 2021 Mar; 19(1):80. PubMed ID: 33775248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Masked hypergraph learning for weakly supervised histopathology whole slide image classification.
    Shi J; Shu T; Wu K; Jiang Z; Zheng L; Wang W; Wu H; Zheng Y
    Comput Methods Programs Biomed; 2024 Aug; 253():108237. PubMed ID: 38820715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High accuracy epidermal growth factor receptor mutation prediction via histopathological deep learning.
    Zhao D; Zhao Y; He S; Liu Z; Li K; Zhang L; Zhang X; Wang S; Che N; Jin M
    BMC Pulm Med; 2023 Jul; 23(1):244. PubMed ID: 37407963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
    Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
    Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung Cancer Diagnosis on Virtual Histologically Stained Tissue Using Weakly Supervised Learning.
    Chen Z; Wong IHM; Dai W; Lo CTK; Wong TTW
    Mod Pathol; 2024 Jun; 37(6):100487. PubMed ID: 38588884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Epidermal Growth Factor Receptor Mutation With Major Histologic Subtype of Lung Adenocarcinoma According to IASLC/ATS/ERS Classification.
    Boukansa S; Benbrahim Z; Gamrani S; Bardai S; Bouguenouch L; Mazti A; Boutahiri N; Serraj M; Amara B; Ouadnouni Y; Smahi M; Alami B; Mellas N; El Fatemi H
    Cancer Control; 2022; 29():10732748221084930. PubMed ID: 35348028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting AI-based mutation prediction in lung adenocarcinoma: A comprehensive real-world study.
    Dernbach G; Kazdal D; Ruff L; Alber M; Romanovsky E; Schallenberg S; Christopoulos P; Weis CA; Muley T; Schneider MA; Schirmacher P; Thomas M; Müller KR; Budczies J; Stenzinger A; Klauschen F
    Eur J Cancer; 2024 Nov; 211():114292. PubMed ID: 39276594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep learning predicts epidermal growth factor receptor mutation subtypes in lung adenocarcinoma.
    Song J; Ding C; Huang Q; Luo T; Xu X; Chen Z; Li S
    Med Phys; 2021 Dec; 48(12):7891-7899. PubMed ID: 34669994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between common driver gene variations and clinicopathological typing in lung adenocarcinoma].
    Ma XL; Jia RN; Han K; Zhang YX
    Zhonghua Bing Li Xue Za Zhi; 2024 Jun; 53(6):578-584. PubMed ID: 38825903
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative analysis of machine learning approaches to classify tumor mutation burden in lung adenocarcinoma using histopathology images.
    Sadhwani A; Chang HW; Behrooz A; Brown T; Auvigne-Flament I; Patel H; Findlater R; Velez V; Tan F; Tekiela K; Wulczyn E; Yi ES; Mermel CH; Hanks D; Chen PC; Kulig K; Batenchuk C; Steiner DF; Cimermancic P
    Sci Rep; 2021 Aug; 11(1):16605. PubMed ID: 34400666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.
    Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D
    Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting EGFR mutation status in lung adenocarcinoma on computed tomography image using deep learning.
    Wang S; Shi J; Ye Z; Dong D; Yu D; Zhou M; Liu Y; Gevaert O; Wang K; Zhu Y; Zhou H; Liu Z; Tian J
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30635290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Vision Transformer for high robustness and generalization in predicting EGFR mutation status in lung adenocarcinoma.
    Weng L; Xu Y; Chen Y; Chen C; Qian Q; Pan J; Su H
    Clin Transl Oncol; 2024 Jun; 26(6):1438-1445. PubMed ID: 38194018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward automatic prediction of EGFR mutation status in pulmonary adenocarcinoma with 3D deep learning.
    Zhao W; Yang J; Ni B; Bi D; Sun Y; Xu M; Zhu X; Li C; Jin L; Gao P; Wang P; Hua Y; Li M
    Cancer Med; 2019 Jul; 8(7):3532-3543. PubMed ID: 31074592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung adenocarcinoma with EGFR L858R-K860I and L858R-L861F doublet mutations from which the L858R mutation is undetectable through the cobas EGFR mutation test v2.
    Wu CH; Zhang MS; Huang YL; Cheng WH; Lai JY; Hsieh MS; Liao WY
    Pathol Res Pract; 2024 May; 257():155304. PubMed ID: 38657557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor mutation status in pulmonary adenocarcinoma: Multi-institutional data discussion at national conference of "Lung Cancer Management in Indian context".
    Nakra T; Mehta A; Bal A; Nambirajan A; Mishra D; Midha D; Gupta N; Arora N; Gupta P; Gupta P; Singh V; Jain D
    Curr Probl Cancer; 2020 Jun; 44(3):100561. PubMed ID: 32169258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Picoliter-Droplet Digital Polymerase Chain Reaction-Based Analysis of Cell-Free Plasma DNA to Assess EGFR Mutations in Lung Adenocarcinoma That Confer Resistance to Tyrosine-Kinase Inhibitors.
    Seki Y; Fujiwara Y; Kohno T; Takai E; Sunami K; Goto Y; Horinouchi H; Kanda S; Nokihara H; Watanabe S; Ichikawa H; Yamamoto N; Kuwano K; Ohe Y
    Oncologist; 2016 Feb; 21(2):156-64. PubMed ID: 26768482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21.
    Yu JY; Yu SF; Wang SH; Bai H; Zhao J; An TT; Duan JC; Wang J
    Chin J Cancer; 2016 Mar; 35():30. PubMed ID: 27001083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.